VEGFA anticorps (AA 27-232)
Aperçu rapide pour VEGFA anticorps (AA 27-232) (ABIN7567817)
Antigène
Voir toutes VEGFA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 27-232
-
Fonction
- Anti-Human VEGFA Monoclonal Antibody (1A169)
-
Purification
- Protein G purified from mice ascites.
-
Pureté
- >95 %
-
Immunogène
- E. coli - derived recombinant Human VEGFA (Ala27-Arg232).
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.4 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.05 % proclin300, 50 % glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C,-80 °C
-
Stockage commentaire
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
-
- VEGFA (Vascular Endothelial Growth Factor A (VEGFA))
-
Autre désignation
- VEGFA
-
Sujet
- Vascular endothelial growth factor A,VPF,VEGFA,VEGF,Vascular permeability factor,VEGF-A,
-
Pathways
- Signalisation RTK, Glycosaminoglycan Metabolic Process, Regulation of Cell Size, Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Antigène
-